ASIC approves C3 name change

By Dylan Bushell-Embling
Tuesday, 17 June, 2008

The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.

The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.

TGA approves donanemab for treatment of early Alzheimer's

The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...

Ultra-processed foods linked to poor health, premature death

Evidence suggests a dose-response relationship between ultra-processed food consumption and...

Shorter radiotherapy course proves safe for prostate cancer

A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...

Content from other channels on our network

Digital displays in health care: benefits for patients and staff

Doctors' warning — Bupa's plans risk a US-style health model

NSWNMA: Proposed workers comp changes a "cruel blow"

Nursing and Midwifery Board waives renewal late fee until 15 June

Victoria's 2025–26 State Budget claims frontline care record

Lithium–CO2 battery provides green energy alternative

City of Gosnells renews WALGA sustainability commitment

Next-gen liquid battery for solar energy from rooftops

Smith & Loveless acquires CST Wastewater Solutions

Grid-free solar streetlights light up Darlington Point

Injectable tech for fresh produce could extend shelf life

Manufacturing most impacted by ransomware in Q1 2025

Balancing packaging waste and food waste through data-driven design

Call for comment on thermolysin as a processing aid

No kidding: Australia's goatmeat exports at all-time high